Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FQSX4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,763
Award facts
- Contract value 100% obligated
- $16,762.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,762.60 to DMS Pharmaceutical Group Inc. on January 15, 2026, for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. The delivery order is firm fixed-price with no set-aside designation and is scheduled for completion by February 6, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, establishes the company as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's extensive experience distributing specialized pharmaceutical products across multiple therapeutic categories demonstrates its capability to fulfill the diverse medical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQSX4?
SPE2DR26FQSX4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FQSX4 worth?
The government has obligated $16,763 on SPE2DR26FQSX4.
Is contract SPE2DR26FQSX4 an order under another contract?
Yes. SPE2DR26FQSX4 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSX4 competed?
The extent of competition for SPE2DR26FQSX4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award